Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT03699748 Completed - Cancer Clinical Trials

Lay Health Worker Engage, Educate, and Encourage Patients to Share

LEAPS
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

The purpose of the LEAPS program is to understand how a trained lay health worker who engages with newly diagnosed patients after a diagnosis of an advanced stage of cancer can help to engage patients in advance care planning, improve patient satisfaction with their decision-making, activation, quality of life, and healthcare resource utilization.

NCT ID: NCT03694171 Completed - Cancer Clinical Trials

Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)

Start date: November 2013
Phase:
Study type: Observational

The growing incidence of cancer associated to an aging population represents an epidemiologic reality that requires questioning access to care and prognosis in elderly with cancer, for which disparities have been highlighted. However, generally speaking, studies are limited in that they overlook geriatric-specific factors. The aim of this work was to study sociodemographic, socioeconomic and clinical determinants of access to care (cancer stage, cancer treatment) and prognosis (functional decline, survival) in elderly cancer patients.

NCT ID: NCT03692624 Completed - Cancer Clinical Trials

Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors

Start date: May 10, 2015
Phase: N/A
Study type: Interventional

Heart rate variability biofeedback (HRV-B) is a complementary, non-pharmacologic therapy that is being tested to see if it can help cancer survivors reduce their symptoms of pain, stress, insomnia, fatigue, or depression. HRV-B is an interactive procedure in which participants relax and breathe regularly while watching the a computer screen. The computer screen provides feedback that helps people increase their heart rate variability.

NCT ID: NCT03690401 Completed - Cancer Clinical Trials

Body Composition Post Cancer Treatment

PostSOZO
Start date: October 1, 2018
Phase:
Study type: Observational

The purpose of this study is to assess how bone density and body composition changes after a cancer patient completes treatment and through 12-weeks post-treatment. Patients who enroll in the 12-week exercise program, Moving On, and those that do not elect to participate in the Moving On program will both be tracked, with assessments including SOZO measurements, DEXA scan (bone density and whole body composition), performance status tests, food log, urine color test, and other study assessments.

NCT ID: NCT03688347 Completed - Cancer Clinical Trials

Microbiome in Lung Cancer and Other Malignancies

Start date: August 30, 2018
Phase:
Study type: Observational

To characterize the fecal, skin, nasal and oral microbiome and metabolome in patients with lung cancer and other malignancies, and correlate to treatment response and toxicities of various therapies including immunotherapy, chemotherapy and targeted therapy, etc.

NCT ID: NCT03684005 Completed - Cancer Clinical Trials

MyPatientPal: An App to Help Patients Manage Their Cancer Care

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

MyPatientPal was developed in collaboration with both patient and oncologist stakeholders, is designed to facilitate such patient self-management through the daily reporting of side effects and medications.

NCT ID: NCT03681873 Completed - Cancer Clinical Trials

Validation of Low Dose CT for Diagnosis of Lung Nodules

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

The investigators have developed an extremely low dose computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of two chest radiographs. The investigators plan to test this exam in patients with known or suspected cancer undergoing clinically indicated chest CT.

NCT ID: NCT03676920 Completed - Cancer Clinical Trials

Feasibility and Utilization of an Application-based Question Prompt List

Start date: August 21, 2018
Phase: N/A
Study type: Interventional

This trial studies how well an application-based question prompt list works in improving treatment cost discussion between patients with breast, prostate, lung, or colorectal cancer and their oncologists. An application-based question prompt list, called Discussion of Cost Application (DISCO App), may help to improve how patients and oncologists discuss cancer treatment costs.

NCT ID: NCT03676270 Completed - Cancer Clinical Trials

Trends in Modern Phase 1 Oncology Trials

Phase 1
Start date: January 2014
Phase:
Study type: Observational

Overview of response rate published in recent oncology phase I trials

NCT ID: NCT03676153 Completed - Cancer Clinical Trials

Integrative Care Training Program for Nurses on Supportive Cancer Care

Start date: November 15, 2018
Phase: N/A
Study type: Interventional

The integration of complementary medicine in supportive and palliative cancer care (i.e., Integrative Oncology) is becoming more prevalent in many of the leading oncology centers in Israel and worldwide. Guidelines for these practices, as established by the Society for Integrative Oncology, were adopted in 2018 by the American Society of Clinical Oncology. The proposed study will be conducted within a pragmatic, randomized and controlled format, and will examine the impact of a nurse-guided intervention on 540 oncology patients undergoing Integrative Oncology treatments for quality of life (QOL)-related concerns during adjuvant/neo-adjuvant or curative/palliative treatments. Patients in both study arms will undergo patient-tailored integrative treatments, which will include manual and relaxation therapies, acupuncture and lifestyle changes. The integrative treatments will be provided by trained integrative oncology practitioners. Patients in the intervention arm of the study will receive additional nurse-guided instruction in the self-administration of manual therapies, relaxation, lifestyle changes and traditional medicine practices.